Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AQXP

Aquinox Pharmaceuticals (AQXP) Stock Price, News & Analysis

Aquinox Pharmaceuticals logo

About Aquinox Pharmaceuticals Stock (NASDAQ:AQXP)

Advanced Chart

Key Stats

Today's Range
$19.98
$22.82
50-Day Range
$3.68
$4.03
52-Week Range
$2.00
$3.84
Volume
201,066 shs
Average Volume
239,362 shs
Market Capitalization
$524.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AQXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aquinox Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AQXP Stock News Headlines

Mirum Pharmaceuticals, Inc. (MIRM)
Why Aquinox Pharma (AQXP) Stock Might be a Great Pick
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

AQXP Stock Analysis - Frequently Asked Questions

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) posted its quarterly earnings data on Thursday, November, 8th. The company reported ($0.64) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.43.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aquinox Pharmaceuticals investors own include Novavax (NVAX), Bausch Health Cos (BHC), Sarepta Therapeutics (SRPT), ACADIA Pharmaceuticals (ACAD), XOMA Royalty (XOMA), Alnylam Pharmaceuticals (ALNY) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2018
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AQXP
CIK
1404644
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.58 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.13%
Return on Assets
-28.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
63.17
Quick Ratio
63.17

Sales & Book Value

Annual Sales
$25 million
Price / Sales
20.96
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.09 per share
Price / Book
7.20

Miscellaneous

Outstanding Shares
23,540,000
Free Float
N/A
Market Cap
$524.00 million
Optionable
Not Optionable
Beta
-7.37
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AQXP) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners